Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

E. Galvani, R. Alfieri, E. Giovannetti, A. Cavazzoni, S. La Monica, M. Galetti, C. Fumarola, M. Bonelli, M. Mor, M. Tiseo, G.J. Peters, P.G. Petronini, A. Ardizzoni

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)818-832
JournalCurrent Pharmaceutical Design
Issue number5
Publication statusPublished - 2013

Cite this